Question · Q3 2026
Susan Anderson inquired about the progress of restocking the Clear Eyes business, the expected timeframe for full stock across all SKUs, and any impact on margins during the supply disruption with anticipated recovery. She also asked for an update on e-commerce penetration, faster-growing online segments, and long-term penetration expectations. Finally, she sought an update on the women's health business, specifically if it was susceptible to consumer shopping patterns or retailer destocking.
Answer
Chris Sacco, CFO and COO, stated that the strategic acquisition of Pillar5 and new suppliers are progressing, but restocking will be a gradual process extending through fiscal year 2027, with sequential improvements expected. He noted that margins remained relatively stable, with no material change expected from eye care supply normalization. Ron Lombardi, Chairman, President, and CEO, reported over 10% consumption growth in e-commerce for Q3 but cautioned against predicting ultimate channel share. He emphasized working with retail partners to meet evolving shopper needs. For women's health, Lombardi highlighted Monistat's strong performance and expansion into new products, while Summer's Eve is well-positioned for long-term growth despite recent volatility, with the overall franchise performing well on a trailing twelve-month basis.
Ask follow-up questions
Fintool can predict
PBH's earnings beat/miss a week before the call


